RxDoctor Payments Data

Timothy Presnell, MD

Obstetrics & Gynecology · Richlands, VANPI 1013908466

Payments from drug & device makers

$1,506in general payments, 2019–2025

Across 77 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exeltis, USA Inc.$543
  • Amgen$237
  • AbbVie$204
  • Novo Nordisk$169
  • Exact Sciences$144
  • Astellas Pharma US Inc$111
  • plus $98 from 4 others

What the payments were for

  • Food & beverage$1,506100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exeltis, USA Inc.34$543
Amgen15$237
AbbVie11$204
Novo Nordisk2$169
Exact Sciences4$144
Astellas Pharma US Inc6$111
Boston Scientific2$48
Merck1$24
Ascend Therapeutics US, LLC1$14
Axonics, Inc.1$12

How this compares

$1,506 in reported general payments places this provider in the 70th percentile of 992 obstetrics & gynecology providers in Virginia.

See all obstetrics & gynecology providers in Virginia

Medicare billing

Part B allowed, 2024
$1,089
Medicare patients
35
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab12$20,912
Estradiol309$16,209
Estradiol (Twice Weekly)Estradiol68$6,198
DottiEstradiol55$4,218
Metronidazole97$2,735
Clobetasol Propionate73$2,645
Medroxyprogesterone Acetate143$2,268
ProgesteroneProgesterone, Micronized39$1,839
Terconazole48$1,323
ValacyclovirValacyclovir Hcl51$1,305
Norethindrone57$1,216
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst28$990
Fluconazole215$929
Solifenacin Succinate30$752
NitrofurantoinNitrofurantoin Macrocrystal24$611

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenProlia$237$20,91212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 992 obstetrics & gynecology providers in Virginia.

Other obstetrics & gynecology in Richlands

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →